Latest Articles
MSK Endometrial Cancer e-Tumor Board - Medscape
MSK Endometrial Cancer e-Tumor Board Medscape
Published: Feb. 10, 2026, 11:06 p.m.
Why is Inoperable Endometrial Cancer Relevant at the 2026 ACRO Summit? - CancerNetwork
Why is Inoperable Endometrial Cancer Relevant at the 2026 ACRO Summit? CancerNetwork
Published: Feb. 10, 2026, 8:43 p.m.
AstraZeneca Imfinzi Approved in India for Endometrial Cancer - Rediff MoneyWiz
AstraZeneca Imfinzi Approved in India for Endometrial Cancer Rediff MoneyWiz
Published: Feb. 10, 2026, 8:42 a.m.
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in endometrial cancer - Express Pharma
AstraZeneca Pharma India receives CDSCO approval for Durvalumab indication in endometrial cancer Express Pharma
Published: Feb. 10, 2026, 6:40 a.m.
AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug - CNBC TV18
AstraZeneca Pharma shares gain as it receives CDSCO nod for import of endometrial cancer treatment drug CNBC TV18
Published: Feb. 10, 2026, 6:11 a.m.
Advancing Precision: The Vital Role of Biomarker Testing in Endometrial Cancer - Targeted Oncology
Advancing Precision: The Vital Role of Biomarker Testing in Endometrial Cancer Targeted Oncology
Published: Feb. 6, 2026, 10:05 p.m.
How Does Rina-S Work in Patients With Pretreated Endometrial Cancer? - Oncology Nursing News
How Does Rina-S Work in Patients With Pretreated Endometrial Cancer? Oncology Nursing News
Published: Feb. 5, 2026, 5:03 p.m.
GSK’s Jemperli Wins Public Reimbursement in Quebec for Endometrial Cancer Indication - NAVLIN DAILY
GSK’s Jemperli Wins Public Reimbursement in Quebec for Endometrial Cancer Indication NAVLIN DAILY
Published: Feb. 5, 2026, 3:44 a.m.
Inoperable To Cancer-Free: Medanta Doctors Achieve Rare Complete Response In Advanced Endometrial Cancer - BW Healthcare World
Inoperable To Cancer-Free: Medanta Doctors Achieve Rare Complete Response In Advanced Endometrial Cancer BW Healthcare World
Published: Feb. 4, 2026, 7:56 a.m.
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer - BioSpace
Quebec first province to publicly reimburse Jemperli (dostarlimab for injection) plus chemotherapy via RAMQ for the treatment of all adult patients with primary advanced or first recurrent endometrial cancer BioSpace
Published: Feb. 4, 2026, 4:47 a.m.
Link copied to clipboard!